Cartesian Therapeutics (RNAC) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cartesian Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswireFeb 18 07:00 ET
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswireFeb 6 07:05 ET
GSK (GSK) Tops Q4 Earnings and Revenue Estimates
Zacks Feb 5 06:21 ET
H.C. Wainwright Maintains Cartesian Therapeutics(RNAC.US) With Buy Rating, Maintains Target Price $45
Moomoo NewsJan 28 06:35 ET · Ratings
Cartesian Therapeutics Says US FDA Agrees to Phase 3 Myasthenia Gravis Trial Design
MT NewswiresJan 27 10:01 ET
Express News | Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 Aurora Trial of Descartes-08 in Myasthenia Gravis
ReutersJan 27 07:00 ET

Comments

Jaguar8

Sep 9, 2024 06:32

NEWS

$Cartesian Therapeutics (RNAC.US)$
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment

Trytosaveabit

Jul 2, 2024 05:31

News

$Cartesian Therapeutics (RNAC.US)$ Press Release: Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
Dow Jones· just

2

Trytosaveabit

Apr 10, 2024 15:53

Update! With 2 new 13D

$Cartesian Therapeutics (RNAC.US)$Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...

1

7

God(S) is Stonk

Mar 27, 2024 13:59

RNAC 👀

$Cartesian Therapeutics (RNAC.US)$ did no one notice springer just bought another 1.9million shares just today 👀, simply does not explain the price action point for this week at all. Eccentric !

God(S) is Stonk

Mar 26, 2024 11:19

$Cartesian Therapeutics (RNAC.US)$ FMR had a top position in Viking Therapeutics, and here in Cartesian as well. The reverse split is to allow more institutions to follow suit. If you were to read the paper closely on the pipeline, their RNA cell therapy extends to a suite of autoimmune diseases. With a production up and coming, more partnership might be announced very soon.

RNAC Cartesian Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks